Identification of HLA a*0201 glioblastoma multiforme cell lines for immunotherapy by PCR-SSP and DNA sequencing

Journal of Neuro-Oncology

Volumn 66, Issue 1-2, 2004, Pages 1-8

  Wu, An Hua ^a   Hall, Walter A ^a   Low, Walter C ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Glioblastoma multiforme; Glioma; HLA; Immunotherapy

Indexed keywords

BETA 2 MICROGLOBULIN; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; PROTEIN; TAPASIN; TRANSPLANTATION ANTIGEN PROTEIN 1; TRANSPLANTATION ANTIGEN PROTEIN 2; UNCLASSIFIED DRUG;

ALLELE; ANTIGEN EXPRESSION; ARTICLE; BRAIN TUMOR; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CELL LEVEL; CONTROLLED STUDY; DNA SEQUENCE; FLOW CYTOMETRY; GENOTYPE; GLIOBLASTOMA; GLIOMA; HEALTH CARE COST; HLA TYPING; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING;

EID: 1342287207     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEON.0000013460.53527.28     Document Type: Article

References (44)

1. Morford LA, Dix AR, Brooks WH, Roszman TL: Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors. J Neurosurg 91(6): 935-946, 1999
2. Galetto A, Contarini M, Sapino A, Cassoni P, Consalvo E, Forno S, Pezzi C, Barnaba V, Mussa A, Matera L: Ex vivo host response to gastrointestinal cancer cells presented by autologous dendritic cells. J Surg Res 100(1): 32-38, 2001
3. Nouri-Shirazi M, Banchereau J, Bell D, Burkeholder S, Kraus ET, Davoust J, Palucka KA: Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses. J Immunol 165(7): 3797-3803, 2000
4. Schnurr M, Galambos P, Scholz C, Then F, Dauer M, Endres S, Eigler A: Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: An in vitro model for the assessment of tumor vaccines. Cancer Res 61(17): 6445-6450, 2001
5. Ni HT, Spellman SR, Jean WC, Hall WA, Low WC: Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas. J Neuro-Oncol 51(1): 1-9, 2001
6. Liau LM, Black KL, Prins RM, Sykes SN, DiPatre PL, Cloughesy TF, Becker DP, Bronstein JM: Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. J Neurosurg 90(6): 1115-1124, 1999
7. Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, Lee PK, Yong WH, Incardona F, Thompson RC, Riedinger MS, Zhang W, Prins RM, Black KL: Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res 61(3): 842-847, 2001
8. Elliott LH, Brooks WH, Roszman TL: Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors. J Immunol 132(3): 1208-1215, 1984
9. Elliott LH, Brooks WH, Roszman TL: Activation of immunoregulatory lymphocytes obtained from patients with malignant gliomas. J Neurosurg 67(2): 231-236, 1987
10. McVicar DW, Davis DF, Merchant RE: In vitro analysis of the proliferative potential of T cells from patients with brain tumor: Glioma-associated immunosuppression unrelated to intrinsic cellular defect. J Neurosurg 76(2): 251-260, 1992
11. Dix AR, Brooks WH, Roszman TL, Morford LA: Immune defects observed in patients with primary malignant brain tumors. J Neuroimmunol 100(1-2): 216-232, 1999
12. Morford LA, Elliott LH, Carlson SL, Brooks WH, Roszman TL: T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. J Immunol 159(9): 4415-4425, 1997
13. Heukamp LC, Van Der Burg SH, Drijfhout JW, Melief CJ, Taylor-Papadimitriou J, Offringa R: Identification of three non-VNTR MUC1-derived HLA-A*0201-restricted T-cell epitopes that induce protective anti-tumor immunity in HLA-A2/K(b)-transgenic mice. Int J Cancer 91(3):385-392, 2001
14. Keogh E, Fikes J, Southwood S, Celis E, Chesnut R, Sette A: Identification of new epitopes from four different tumor-associated antigens: Recognition of naturally processed epitopes correlates with HLA-A*0201-binding affinity. J Immunol 167(2): 787-796, 2001
15. Mullins DW, Bullock TN, Colella TA, Robila VV, Engelhard VH: Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice. J Immunol 167(9): 4853-4860, 2001
16. Pascolo S, Schirle M, Guckel B, Dumrese T, Stumm S, Kayser S, Moris A, Wallwiener D, Rammensee HG, Stevanovic S: A MAGE-A1 HLA-A A*0201 epitope identified by mass spectrometry. Cancer Res 61(10): 4072-4077, 2001
17. Gatz SA, Pohla H, Schendel DJ: A PCR-SSP method to specifically select HLA-A*0201 individuals for immunotherapeutic studies. Tissue Antigens 55(6): 532-547, 2000
18. Eifuku R, Takenoyama M, Yoshino I, Imahayashi S, So T, Yasuda M, Sugaya M, Yasumoto K: Analysis of MAGE-3 derived synthetic peptide as a human lung cancer antigen recognized by cytotoxic T lymphocytes. Int J Clin Oncol 6(1): 34-39, 2001
19. Serrano A, Tanzarella S, Lionello I, Mendez R, Traversari C, Ruiz-Cabello F, Garrido F: Repression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2′-deoxycytidine treatment. Int J Cancer 94(2): 243-251, 2001
20. Blasczyk R, Hahn U, Wehling J, Huhn D, Salama A: Complete subtyping of the HLA-A locus by sequence-specific amplification followed by direct sequencing or single-strand conformation polymorphism analysis. Tissue Antigens 46(2): 86-95, 1995
21. Browning MJ, Krausa P, Rowan A, Bicknell DC, Bodmer JG, Bodmer WF: Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: Comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc Natl Acad Sci USA 90(7): 2842-2845, 1993
22. Bunce M, Procter J, Dunn PP, Day S, Ross J, Welsh KI: Identification of the null HLA-A2 allele, A*0232N. Tissue Antigens 55(1): 31-36, 2000
23. Erlich HA, Sheldon EL, Horn G: HLA typing using DNA probes. Biotechnology 4: 975-981, 1986
24. Krausa P, Bodmer JG, Browning MJ: Defining the common subtypes of HLA A9, A10, A28 and A19 by use of ARMS/PCR. Tissue Antigens 42(2): 91-99, 1993
25. Wen P, Lampson MA, Lampson LA: Effects of gamma interferon on major histocompatibility complex antigen expression and lymphocytic infiltration in the 9L gliosarcoma brain tumor model: Implications for strategies of immunotherapy. J Neuroimmunol 36: 57-68, 1992
26. Akiyama H, Itagaki S, McGeer PL: Major histocompatibility complex antigen expression on rat microglia following epidural kainic acid lesion. J Neurosci Res 20: 147-157, 1988
27. Gogate N, Bakhiet M, Kristensson K, Norrby E, Olsson T: Gamma interferon expression and major histocompatibility complex (MHC) antigens in the developing CNS. J Neuroimmunol 31: 19-26, 1991
28. Matsumoto Y, Fujiwara M: In situ detection of class I and II major histocompatibility complex antigens in the rat central nervous system during experimental allergic encephalomyelitis. J Neuroimmunol 12: 265-277, 1986
29. Olsson T, Maehlen J, Love A, Klareskog L, Norrby E, Kristensson K: Induction of class I and class II transplantation antigens in rat brain during fatal and non-fatal measles virus infection. J Neuroimmunol 43: 45-58, 1987
30. Schultzberg M, Olsson T, Samuelsson E-B, Maehlen J, Kristensson K: Early major histocompatibility complex (MHC) class I antigen induction in hypothalamic supraoptic and paraventricular nuclei in trypanosome-infected rats. J Neuroimmunol 24: 105-112, 1989
31. Sethna MP, Lampson LA: Immune modulation within the brain: Recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma. J Neuroimmunol 34: 121-132, 1991
32. Vass K, Lassmann H: Intrathecal application of interferon gamma. Progressive appearance of MHC antigens within the rat nervous system. Am J Pathol 137: 789-800, 1990
33. Whelan JP, Eriksson U, Lampson LA: Expression of mouse b2-microglobulin in frozen and formaldehyde-fixed central nervous tissues: Comparison of tissue behind the blood-brain barrier and tissue in a barrier-free region. J Immunol 137: 2561-2566, 1986a
34. Lampson LA and Hickey WF: Monoclonal antibody analysis of MHC expression in human brain biopsies: Tissue ranging from 'histologically normal' to that showing different levels of glial tumor involvement. J Immunol 136: 4054-4062, 1986
35. Lampson LA, Kushner PD, Sobel RA: Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis. Ann Neurol 28: 365-372, 1990
36. Itagaki S, McGeer PL, Akiyama H: Presence of T-cytotoxic suppressor and leukocyte common antigen positive cells in Alzheimer's disease brain tissue. Neurosci Lett 91: 259-264, 1988
37. Sobel RA and Ames MB: Major histocompatibility complex molecule expression in the human central nervous system: Immunohistochemical analysis of 40 patients. J Neuropathol Exp Neurol 47: 19-28, 1988
38. Traugott U: Multiple sclerosis: Relevance of class I and class II MHC-expressing cells to lesion development. J Neuroimmunol 16: 283-302, 1987
39. Alimonti J, Zhang QJ, Gabathuler R, Reid G, Chen SS, Jefferies WA: TAP expression provides a general method for improving the recognition of malignant cells in vivo. Nat Biotechnol 18(5): 515-520, 2000
40. Li S, Paulsson KM, Chen S, Sjogren HO, Wang P: Tapasin is required for efficient peptide binding to transporter associated with antigen processing. J Biol Chem 275(3): 1581-1586, 2000
41. Murray JL, Hudson JM, Ross MI, Zhang HZ, Ioannides CG: Reduced recognition of metastatic melanoma cells by autologous MART-1 specific CTL: Relationship to TAP expression. J Immunother 23(1): 28-35, 2000
42. Kuan CT, Wikstrand CJ, Bigner DD: EGF mutant receptor VIII as a molecular target in cancer therapy. Endocr Relat Cancer 8(2): 83-96, 2001
43. Debinsky W, Gibo DM: Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen. Mol Med 6(5): 440-449, 2000
44. Sutmuller RP, Schurmans LR, Van Duivenvoorde LM, Tine JA, Van Der Voort El, Toes RE, Melief CJ, Jager MJ, Offringa R: Adoptive T cell immunotherapy of human uveal melanoma targeting gp100. J Immunol 165(12): 7308-7315, 2000